Company · CIK 0001720580 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Adicet Bio, Inc. · ACET
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 AForm 4 → | Aug 7, 4:01 pm EDT | Lloyd KlicksteinChief Medical Officer, Director | 18,300 | — | — | 18,300 | — | |
| Jun 21, 2026 AForm 4 → | Jun 23, 4:31 pm EDT | Steve DubinDirector | 4,200 | — | — | 4,200 | — | |
| Jun 21, 2026 AForm 4 → | Jun 23, 4:30 pm EDT | Jeffrey ChodakewitzDirector | 4,200 | — | — | 4,200 | — | |
| Jun 21, 2026 AForm 4 → | Jun 23, 4:29 pm EDT | Michael GrissingerDirector | 4,200 | — | — | 4,200 | — | |
| Jun 21, 2026 AForm 4 → | Jun 23, 4:27 pm EDT | Andrew SinclairDirector | 4,200 | — | — | 4,200 | — | |
| Jun 21, 2026 AForm 4 → | Jun 23, 4:26 pm EDT | Katie PengDirector | 4,200 | — | — | 4,200 | — | |
| Jun 21, 2026 AForm 4 → | Jun 23, 4:25 pm EDT | Lloyd KlicksteinDirector | 4,200 | — | — | 4,200 | — | |
| Jun 19, 2026 AForm 4 → | Jun 23, 6:51 pm EDT | Chen SchorPresident & CEO, Director | 55,000 | — | — | 55,000 | — | |
| Jun 19, 2026 AForm 4 → | Jun 23, 6:49 pm EDT | Blake AftabChief Scientific Officer | 55,000 | — | — | 55,000 | — |